Create an Account
Welcome & Mission Statement
User Technical Support
Accreditation Legend
System Requirements
This activity already occurred and is no longer available.
Business or Exploitation? Exposure of the Tobacco Industry’s Exploitation of Individuals with Mental Health Conditions
The UCSF Smoking Cessation Leadership Center (SCLC) presented this webinar on January 18, 2018 at 1:00pm Eastern Time / 10:00am Pacific Time (60 minutes).

   "Business or Exploitation?"

Exposure of the Tobacco Industry's Exploitation of Individuals with Mental Health Conditions

presented by:

Margaret Jaco Manecke, MSSW
Project Manager, Practice Improvement
National Council for Behavioral Health
Washington, DC

Ashley Persie
Senior Brand Marketing Associate
Truth Initiative®
Washington, DC
Judith Prochaska, PhD, MPH
Associate Professor of Medicine
Stanford University
Palo Alto, California

The Smoking Cessation Leadership Center (SCLC), in conjunction with the National Behavioral Health Network for Tobacco and Cancer Control (NBHN), and the Truth Initiative®, hosted its 75th webinar on January 18, 2018 at 10:00 am Pacific time (60 minutes). You may claim CME credit here for your participation after the webinar has concluded. 

Learning Objectives

At the end of this activity, the participant should be able to:
  1. Explain why people with mental health conditions (depression and ADHD, for example) and substance use disorders have been historically targeted by the tobacco industry.
  2. State whether adults with mental health conditions and substance use disorders smoke more than adults without those conditions.
  3. Describe the morbidity rates of people with mental health conditions and name specific causes of death that can be attributed to tobacco use.  
  4. Explain the impact of the truth® campaign among its target audience.  
  5. Describe evidence-based approaches for treating tobacco use and tobacco addiction in persons with co-occurring mental illness.
  6. Describe how you can leverage the National Behavioral Health Network for Tobacco & Cancer Control’s tools, resources, and network to combat tobacco use & cancer disparities among individuals with mental illnesses and addictions and network members.

You will need a CMECalifornia (UC Online) account to register and claim CME credit for this activity.

If you do not already have an account with, please click Create an Account to establish one.  You may then login with your email address and password.

This webinar is offered complimentary by the Smoking Cessation Leadership Center.  You will receive an access code upon verification of your participation.  Use the access code provided by the host to proceed in claiming credit.

The fee to register for and claim CME credit is $45.   For a limited time, use discount code SCLC10 for complimentary CME credit, courtesy of SCLC.

Cancellations and Refunds: Cancellations should be made in writing within 7 days of enrollment. Refunds will only be made in the event that technical difficulties prevent completion of the activity, or if no interaction with the material occurred because of inadvertent or mistaken enrollment, or expiration of the activity before the learner had the opportunity to complete it fully. Fees can be transferred to another activity in the case of mistaken enrollment.

Special Needs or Other Concerns: If you require any special accommodations for a disability which creates a hardship to participating in this activity, or you have questions or concerns about this course, please contact the Office of CME. (Additional contact information is below.)

Claiming your Credit

To obtain CME credit, participants must attend the entire webinar and complete a short evaluation survey.  Your certificate will be available immediately for print or download upon completion of the entire activity.  The estimated time to complete this live web activity is 60 minutes, which is equivalent to 1.0 credits. 


This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
All planning committee members and reviewers have disclosed they have no relevant financial interest/arrangement or affiliation with any commercial companies who provide products or services relating to their presentation(s) in this continuing medical education activity.
Christine Cheng
Brian Clark
Jennifer Matekuare
Roxana Said, MPH
Catherine Saucedo
Steven A. Schroeder, MD 

The speakers, Margaret Jaco Manecke and Ashley Persie, have disclosed each has no financial interest/arrangement or affiliation with any commercial companies who provide products or services relating to their presentation(s) for this continuing medical education activity:

The following faculty speaker has disclosed a financial interest/arrangement or affiliation with a commercial company who provides products or services relating to their presentation(s) for this continuing medical education activity. All conflicts of interest have been resolved in accordance with the ACCME Standards for Commercial Support:

Judith Prochaska, PhD, MPH
    Pfizer – Advisor/Reviewer, Consultant
    Carrot - Advisor/Reviewer, Consultant
    MD Revolution - Consultant
    Plaintiffs' law firms - Consultant on lawsuits against tobacco companies

*Be advised that the last three companies in the list are not commercial interests as defined by the Accreditation Council for CME, and are provided here to the participant for transparency reasons.


The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Registered Nurses:
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Physician Assistants:
The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

California Pharmacists:
The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 credit™. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

Supplemental Material: 

Cultural and Linguistic Competency Resources  
CLC Info and Resources

UC Online Privacy Policy


UCSF School of Medicine
Office of Continuing Medical Education
3333 California Street, Suite 450
San Francisco, CA  94118
Phone: (415) 476-4251 • Fax: (415) 476-0318

Type:     Internet Live Course
63 Registered Users